Skip to content

Clinical trials

Graves Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graves Disease Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20123
20141
20173
20182
20221
20232
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Unknown status6
Completed3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
First Affiliated Hospital of Harbin Medical University3
Shanghai Zhongshan Hospital3
Sun Yat-sen University2
Xiao-Ming Mao2
Changchun GeneScience Pharmaceutical Co., Ltd.1
First Hospital of China Medical University1
Peking Union Medical College Hospital1
Qilu Hospital of Shandong University1
Shandong Provincial Hospital1
Shanghai Changzheng Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graves Disease19
Graves Ophthalmopathy3
Autoimmune Diseases2
Endocrine System Diseases2
Eye Diseases, Hereditary2
Hashimoto Disease2
Hyperthyroidism2
Immune System Diseases2
Thyroid Diseases2
COVID-191

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.